Global Tourette Syndrome Drug Market Professional Survey Report 2018

January 2018 | 102 pages | ID: GFE955BEFB5EN
QYResearch

Abstracts

This report studies Tourette Syndrome Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Abide Therapeutics Inc
• Catalyst Pharmaceuticals Inc
• Neurocrine Biosciences Inc
• Psyadon Pharmaceuticals Inc
• Reviva Pharmaceuticals Inc
• Synchroneuron Inc
• Teva Pharmaceutical Industries Ltd
• Therapix Biosciences Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• AZD-5213
• CPP-115
• Dutetrabenazine ER
• Ecopipam Hydrochloride
• Others

By Application, the market can be split into

• Research Center
• Hospital
• Clinic
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Tourette Syndrome Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF TOURETTE SYNDROME DRUG

1.1 Definition and Specifications of Tourette Syndrome Drug
  1.1.1 Definition of Tourette Syndrome Drug
  1.1.2 Specifications of Tourette Syndrome Drug
1.2 Classification of Tourette Syndrome Drug
  1.2.1 AZD-5213
  1.2.2 CPP-115
  1.2.3 Dutetrabenazine ER
  1.2.4 Ecopipam Hydrochloride
  1.2.5 Others
1.3 Applications of Tourette Syndrome Drug
  1.3.1 Research Center
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF TOURETTE SYNDROME DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Tourette Syndrome Drug
2.3 Manufacturing Process Analysis of Tourette Syndrome Drug
2.4 Industry Chain Structure of Tourette Syndrome Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF TOURETTE SYNDROME DRUG

3.1 Capacity and Commercial Production Date of Global Tourette Syndrome Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Tourette Syndrome Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Tourette Syndrome Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Tourette Syndrome Drug Major Manufacturers in 2016

4 GLOBAL TOURETTE SYNDROME DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Tourette Syndrome Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Tourette Syndrome Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Tourette Syndrome Drug Sales and Growth Rate Analysis
  4.3.2 2016 Tourette Syndrome Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Tourette Syndrome Drug Sales Price
  4.4.2 2016 Tourette Syndrome Drug Sales Price Analysis (Company Segment)

5 TOURETTE SYNDROME DRUG REGIONAL MARKET ANALYSIS

5.1 North America Tourette Syndrome Drug Market Analysis
  5.1.1 North America Tourette Syndrome Drug Market Overview
  5.1.2 North America 2012-2017E Tourette Syndrome Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Tourette Syndrome Drug Sales Price Analysis
  5.1.4 North America 2016 Tourette Syndrome Drug Market Share Analysis
5.2 China Tourette Syndrome Drug Market Analysis
  5.2.1 China Tourette Syndrome Drug Market Overview
  5.2.2 China 2012-2017E Tourette Syndrome Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Tourette Syndrome Drug Sales Price Analysis
  5.2.4 China 2016 Tourette Syndrome Drug Market Share Analysis
5.3 Europe Tourette Syndrome Drug Market Analysis
  5.3.1 Europe Tourette Syndrome Drug Market Overview
  5.3.2 Europe 2012-2017E Tourette Syndrome Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Tourette Syndrome Drug Sales Price Analysis
  5.3.4 Europe 2016 Tourette Syndrome Drug Market Share Analysis
5.4 Southeast Asia Tourette Syndrome Drug Market Analysis
  5.4.1 Southeast Asia Tourette Syndrome Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Tourette Syndrome Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Tourette Syndrome Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Tourette Syndrome Drug Market Share Analysis
5.5 Japan Tourette Syndrome Drug Market Analysis
  5.5.1 Japan Tourette Syndrome Drug Market Overview
  5.5.2 Japan 2012-2017E Tourette Syndrome Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Tourette Syndrome Drug Sales Price Analysis
  5.5.4 Japan 2016 Tourette Syndrome Drug Market Share Analysis
5.6 India Tourette Syndrome Drug Market Analysis
  5.6.1 India Tourette Syndrome Drug Market Overview
  5.6.2 India 2012-2017E Tourette Syndrome Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Tourette Syndrome Drug Sales Price Analysis
  5.6.4 India 2016 Tourette Syndrome Drug Market Share Analysis

6 GLOBAL 2012-2017E TOURETTE SYNDROME DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Tourette Syndrome Drug Sales by Type
6.2 Different Types of Tourette Syndrome Drug Product Interview Price Analysis
6.3 Different Types of Tourette Syndrome Drug Product Driving Factors Analysis
  6.3.1 AZD-5213 of Tourette Syndrome Drug Growth Driving Factor Analysis
  6.3.2 CPP-115 of Tourette Syndrome Drug Growth Driving Factor Analysis
  6.3.3 Dutetrabenazine ER of Tourette Syndrome Drug Growth Driving Factor Analysis
  6.3.4 Ecopipam Hydrochloride of Tourette Syndrome Drug Growth Driving Factor Analysis
  6.3.5 Others of Tourette Syndrome Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E TOURETTE SYNDROME DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Tourette Syndrome Drug Consumption by Application
7.2 Different Application of Tourette Syndrome Drug Product Interview Price Analysis
7.3 Different Application of Tourette Syndrome Drug Product Driving Factors Analysis
  7.3.1 Research Center of Tourette Syndrome Drug Growth Driving Factor Analysis
  7.3.2 Hospital of Tourette Syndrome Drug Growth Driving Factor Analysis
  7.3.3 Clinic of Tourette Syndrome Drug Growth Driving Factor Analysis
  7.3.4 Others of Tourette Syndrome Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF TOURETTE SYNDROME DRUG

8.1 Abide Therapeutics Inc
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Abide Therapeutics Inc 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Abide Therapeutics Inc 2016 Tourette Syndrome Drug Business Region Distribution Analysis
8.2 Catalyst Pharmaceuticals Inc
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Catalyst Pharmaceuticals Inc 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Catalyst Pharmaceuticals Inc 2016 Tourette Syndrome Drug Business Region Distribution Analysis
8.3 Neurocrine Biosciences Inc
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Neurocrine Biosciences Inc 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Neurocrine Biosciences Inc 2016 Tourette Syndrome Drug Business Region Distribution Analysis
8.4 Psyadon Pharmaceuticals Inc
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Psyadon Pharmaceuticals Inc 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Psyadon Pharmaceuticals Inc 2016 Tourette Syndrome Drug Business Region Distribution Analysis
8.5 Reviva Pharmaceuticals Inc
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Reviva Pharmaceuticals Inc 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Reviva Pharmaceuticals Inc 2016 Tourette Syndrome Drug Business Region Distribution Analysis
8.6 Synchroneuron Inc
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Synchroneuron Inc 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Synchroneuron Inc 2016 Tourette Syndrome Drug Business Region Distribution Analysis
8.7 Teva Pharmaceutical Industries Ltd
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Teva Pharmaceutical Industries Ltd 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Teva Pharmaceutical Industries Ltd 2016 Tourette Syndrome Drug Business Region Distribution Analysis
8.8 Therapix Biosciences Ltd
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Therapix Biosciences Ltd 2016 Tourette Syndrome Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Therapix Biosciences Ltd 2016 Tourette Syndrome Drug Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF TOURETTE SYNDROME DRUG MARKET

9.1 Global Tourette Syndrome Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Tourette Syndrome Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Tourette Syndrome Drug Sales Price Forecast
9.2 Tourette Syndrome Drug Regional Market Trend
  9.2.1 North America 2017-2022 Tourette Syndrome Drug Consumption Forecast
  9.2.2 China 2017-2022 Tourette Syndrome Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Tourette Syndrome Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Tourette Syndrome Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Tourette Syndrome Drug Consumption Forecast
  9.2.6 India 2017-2022 Tourette Syndrome Drug Consumption Forecast
9.3 Tourette Syndrome Drug Market Trend (Product Type)
9.4 Tourette Syndrome Drug Market Trend (Application)

10 TOURETTE SYNDROME DRUG MARKETING TYPE ANALYSIS

10.1 Tourette Syndrome Drug Regional Marketing Type Analysis
10.2 Tourette Syndrome Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Tourette Syndrome Drug by Region
10.4 Tourette Syndrome Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF TOURETTE SYNDROME DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL TOURETTE SYNDROME DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Tourette Syndrome Drug
Table Product Specifications of Tourette Syndrome Drug
Table Classification of Tourette Syndrome Drug
Figure Global Production Market Share of Tourette Syndrome Drug by Type in 2016
Figure AZD-5213 Picture
Table Major Manufacturers of AZD-5213
Figure CPP-115 Picture
Table Major Manufacturers of CPP-115
Figure Dutetrabenazine ER Picture
Table Major Manufacturers of Dutetrabenazine ER
Figure Ecopipam Hydrochloride Picture
Table Major Manufacturers of Ecopipam Hydrochloride
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Tourette Syndrome Drug
Figure Global Consumption Volume Market Share of Tourette Syndrome Drug by Application in 2016
Figure Research Center Examples
Table Major Consumers in Research Center
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Tourette Syndrome Drug by Regions
Figure North America Tourette Syndrome Drug Market Size (Million USD) (2012-2022)
Figure China Tourette Syndrome Drug Market Size (Million USD) (2012-2022)
Figure Europe Tourette Syndrome Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Tourette Syndrome Drug Market Size (Million USD) (2012-2022)
Figure Japan Tourette Syndrome Drug Market Size (Million USD) (2012-2022)
Figure India Tourette Syndrome Drug Market Size (Million USD) (2012-2022)
Table Tourette Syndrome Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Tourette Syndrome Drug in 2016
Figure Manufacturing Process Analysis of Tourette Syndrome Drug
Figure Industry Chain Structure of Tourette Syndrome Drug
Table Capacity and Commercial Production Date of Global Tourette Syndrome Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Tourette Syndrome Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Tourette Syndrome Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Tourette Syndrome Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Tourette Syndrome Drug 2012-2017
Figure Global 2012-2017E Tourette Syndrome Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Tourette Syndrome Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Tourette Syndrome Drug Capacity and Growth Rate
Table 2016 Global Tourette Syndrome Drug Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Tourette Syndrome Drug Sales (K Pcs) and Growth Rate
Table 2016 Global Tourette Syndrome Drug Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Tourette Syndrome Drug Sales Price (USD/Pcs)
Table 2016 Global Tourette Syndrome Drug Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Tourette Syndrome Drug 2012-2017E
Figure North America 2012-2017E Tourette Syndrome Drug Sales Price (USD/Pcs)
Figure North America 2016 Tourette Syndrome Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Tourette Syndrome Drug 2012-2017E
Figure China 2012-2017E Tourette Syndrome Drug Sales Price (USD/Pcs)
Figure China 2016 Tourette Syndrome Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Tourette Syndrome Drug 2012-2017E
Figure Europe 2012-2017E Tourette Syndrome Drug Sales Price (USD/Pcs)
Figure Europe 2016 Tourette Syndrome Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Tourette Syndrome Drug 2012-2017E
Figure Southeast Asia 2012-2017E Tourette Syndrome Drug Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Tourette Syndrome Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Tourette Syndrome Drug 2012-2017E
Figure Japan 2012-2017E Tourette Syndrome Drug Sales Price (USD/Pcs)
Figure Japan 2016 Tourette Syndrome Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Tourette Syndrome Drug 2012-2017E
Figure India 2012-2017E Tourette Syndrome Drug Sales Price (USD/Pcs)
Figure India 2016 Tourette Syndrome Drug Sales Market Share
Table Global 2012-2017E Tourette Syndrome Drug Sales (K Pcs) by Type
Table Different Types Tourette Syndrome Drug Product Interview Price
Table Global 2012-2017E Tourette Syndrome Drug Sales (K Pcs) by Application
Table Different Application Tourette Syndrome Drug Product Interview Price
Table Abide Therapeutics Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abide Therapeutics Inc Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Abide Therapeutics Inc Tourette Syndrome Drug Business Region Distribution
Table Catalyst Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Business Region Distribution
Table Neurocrine Biosciences Inc Information List
Table Product A Overview
Table Product B Overview
Table 2015 Neurocrine Biosciences Inc Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Neurocrine Biosciences Inc Tourette Syndrome Drug Business Region Distribution
Table Psyadon Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Business Region Distribution
Table Reviva Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Business Region Distribution
Table Synchroneuron Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Synchroneuron Inc Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Synchroneuron Inc Tourette Syndrome Drug Business Region Distribution
Table Teva Pharmaceutical Industries Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Business Region Distribution
Table Therapix Biosciences Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 Therapix Biosciences Ltd Tourette Syndrome Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Therapix Biosciences Ltd Tourette Syndrome Drug Business Region Distribution
Figure Global 2017-2022 Tourette Syndrome Drug Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Tourette Syndrome Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Tourette Syndrome Drug Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Tourette Syndrome Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Tourette Syndrome Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Tourette Syndrome Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Tourette Syndrome Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Tourette Syndrome Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Tourette Syndrome Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Tourette Syndrome Drug by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Tourette Syndrome Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Tourette Syndrome Drug by Region